David Robinson

David Robinson

Auto-generated profile, based on publicly available information

David Robinson

Department of Neurology and Rehabilitation Medicine, University of Cincinnati, OH

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2022 in Neurology
Verified
Journal Article
Closed access
PDF file
DRDavid Joseph Robinson
David Joseph Robinson
RSRobert Stanton
Robert Stanton
HSHeidi Sucharew
Heidi Sucharew
KAKathleen Alwell
Kathleen Alwell
MHMary Haverbusch
Mary Haverbusch
DKDawn O. Kleindorfer
Dawn O. Kleindorfer
Background and Objective There are significant racial disparities in stroke in the United States, with Black individuals having a higher risk of incident stroke even when adjusted for traditional stroke risk factors. It is unknown whether Black individuals are also at a higher risk of recurrent stroke. Methods Over an 18-month period spanning 2014–2015, we ascertained index stroke cases within the Greater Cincinnati/Northern Kentucky population of 1.3 million. We then followed up all patients for 3 years and determined the risk of recurrence. Multivariable survival analysis was performed to determine the effect of Black race on recurrence. Results There were 3,816 patients with index stroke/TIA events in our study period, and 476 patients had a recurrent event within 3 years. The Kaplan-Meier estimate of 3-year recurrence rate was 15.4%. Age-adjusted and sex-adjusted stroke recurrence rate was higher in Black individuals (HR 1.34, 95% CI 1.1–1.6; p = 0.003); however, when adjusted for traditional stroke risk factors including hypertension, diabetes, smoking status, age, and left ventricular hypertrophy, the association between Black race and recurrence was significantly attenuated and became nonsignificant (HR 1.1, 95% CI 0.9–1.36, p = 0.32). At younger ages, Black race was more strongly associated with recurrence, and this effect may not be fully attenuated by traditional stroke risk factors. Discussion Recurrent stroke was more common among Black individuals, but the magnitude of the racial difference was substantially attenuated and became nonsignificant when adjusted for traditional stroke risk factors. Interventions targeting these risk factors could reduce disparities in stroke recurrence.

1 June 2018 in Neurology Clinical Practice
Verified
Journal Article
Closed access
PDF file
ARAlexandra Reynolds
Alexandra Reynolds
BRBenjamin Rohaut
Benjamin Rohaut
MHManisha G. Holmes
Manisha G. Holmes
DRDavid Robinson
David Robinson
WRWilliam Roth
William Roth
JCJan Claassen
Jan Claassen
Background It is unknown whether postanoxic cortical and subcortical myoclonus are distinct entities with different prognoses. Methods In this retrospective cohort study of 604 adult survivors of cardiac arrest over 8.5 years, we identified 111 (18%) patients with myoclonus. Basic demographics and clinical characteristics of myoclonus were collected. EEG reports, and, when available, raw video EEG, were reviewed, and all findings adjudicated by 3 authors blinded to outcomes. Myoclonus was classified as cortical if there was a preceding, time-locked electrographic correlate and otherwise as subcortical. Outcome at discharge was determined using Cerebral Performance Category. Results Patients with myoclonus had longer arrests with less favorable characteristics compared to patients without myoclonus. Cortical myoclonus occurred twice as often as subcortical myoclonus (59% vs 23%, respectively). Clinical characteristics during hospitalization did not distinguish the two. Rates of electrographic seizures were higher in patients with cortical myoclonus (43%, vs 8% with subcortical). Survival to discharge was worse for patients with myoclonus compared to those without (26% vs 39%, respectively), but did not differ between subcortical and cortical myoclonus (24% and 26%, respectively). Patients with cortical myoclonus were more likely to be discharged in a comatose state than those with subcortical myoclonus (82% vs 33%, respectively). Among survivors, good functional outcome at discharge was equally possible between those with cortical and subcortical myoclonus (12% and 16%, respectively). Conclusions Cortical and subcortical myoclonus are seen in every sixth patient with cardiac arrest and cannot be distinguished using clinical criteria. Either condition may have good functional outcomes.

1 February 2026 in Stroke
Verified
Journal Article
Closed access
DRDavid Robinson
David Robinson
LDLili Ding
Lili Ding
RSRobert J. Stanton
Robert J. Stanton
EMEva Mistry
Eva Mistry
DKDawn Kleindorfer
Dawn Kleindorfer
BKBrett Kissela
Brett Kissela
BACKGROUND: Despite a rising public health burden, there have been few population-based studies of chronic subdural hematomas (cSDH) in the United States. We provide the first estimates of cSDH incidence and mortality in a large, representative U.S. population. METHODS: In a representative 5-county region of Southern Ohio and Northern Kentucky, all adults with cSDH in 2019 and 2020 were identified and adjudicated by study physicians. Incidence rates were estimated and standardized to the US population based on age, sex, and race; 30-day and 1-year mortality rates were also estimated. The cause of death was determined using the National Death Index. RESULTS: A total of 353 patients with cSDH were identified. The median age was 76 (IQR, 65–85), 231 were men (65.4%), and 78 were Black (22.1%). Clinical frailty was prevalent among patients (the median retrospective score on the clinical frailty scale was 4), and only 128 (36.3%) were functionally unimpaired at baseline. The regional incidence rate was 16.3 cases/100 000 persons/y (95% CI, 13.9–19.0). Incidence was age- and sex-dependent, with men 85 and older having an incidence rate of 354.8 cases/100 000 persons/y (95% CI, 242.7–500.9). When adjusted to national demographics, the estimated overall US incidence rate was 17.3 cases/100 000 persons/y (95% CI, 14.7–19.9). The 30-day mortality rate after cSDH was 9.4% (95% CI, 6.5–12.9), and the 1-year mortality rate was 32.9% (28.0–38.0). Early mortality (≤30 days) was often partly or fully attributed to the cSDH (48.4% versus 16.1%; P =0.0004), whereas the most common causes of later mortality were neurodegenerative and cardiovascular diseases (27.2% and 28.4%, respectively). CONCLUSIONS: Our contemporary population-level data show that cSDH is common in the US and primarily afflicts patients with a high degree of functional impairment and frailty. While short-term mortality is low, longer-term mortality is high and often related to comorbid illnesses.

9 March 2012 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Open access
PDF file
VSVanja Sikirica
Vanja Sikirica
MBMichael S. Broder
Michael S. Broder
ECEunice Chang
Eunice Chang
PHPiet Hinoul
Piet Hinoul
DRDavid Robinson
David Robinson
MWMalcolm Wilson
Malcolm Wilson
: Objective. To estimate adhesiolysis rates at cesarean delivery (CD) and to estimate costs and clinical implications of performing adhesiolysis at repeat CD. Design. Retrospective cohort using secondary data. Setting. Over 500 acute care hospitals in the USA. Population. Women ≥15 years old with a medical claim for CD between 1 January 2007 and 31 December 2008 who were treated in a hospital that contributed data to the Premier Perspective™ database. Methods. Using data from hospital discharge records, rates of adhesiolysis at the time of CD were calculated. Among patients with repeat CD, a propensity score was used to create matched cohorts with and without adhesiolysis. Unadjusted rates and means were compared between these cohorts. Main outcome measures. Cost, length of stay and selected clinical complications between repeat CD patients with and without adhesiolysis. Results. Adhesiolysis was performed in 0.5% of primary and 6.1% of repeat CD patients. Using propensity scores, 10 261 women who experienced repeat CD with adhesiolysis were matched to 10 261 control women. Hospital cost ($5739 vs. $5448), length of stay (2.97 vs. 2.88 days) and operative time (84.0 vs. 74.2 min) were significantly greater in the adhesiolysis than in the non‐adhesiolysis group (p < 0.01 for all comparisons), as was the overall complication rate (6.3 vs. 3.5%). Conclusions. Adhesiolysis rates were higher in repeat compared with primary CD. Among repeat CD patients, costs and complications were higher in the adhesiolysis group. Reducing adhesion formation after primary CD could reduce cost and complications at the time of repeat CD.

6 October 2021 in Neurocritical Care
Verified
Journal Article
Closed access
PDF file
DRDavid Robinson
David Robinson
JHJed Hartings
Jed Hartings
BFBrandon Foreman
Brandon Foreman

22 July 2021 in International Journal of Stroke
Verified
Journal Article
Closed access
PDF file
DRDavid Robinson
David Robinson
CSCarson Van Sanford
Carson Van Sanford
SKSoo Young Kwon
Soo Young Kwon
ECElisheva Coleman
Elisheva Coleman
PSPadmini Sekar
Padmini Sekar
DWDaniel Woo
Daniel Woo
Objectives: Population-level estimates of the median intracerebral hemorrhage (ICH) volume would allow for the evaluation of clinical trial external validity and determination of temporal trends. We previously reported the median ICH volume in 1988. However, differences in risk factor management, neuroimaging, and demographics may have affected ICH volumes. The goal of this study is to determine the median volume of ICH within a population-based cross-sectional study, including whether it has changed over time. Methods: The Genetic and Environmental Risk Factors for Hemorrhagic Stroke study was a population-based study of ICH among residents of the Greater Cincinnati/Northern Kentucky region from 2008 through 2012. This study utilizes those data and compares with ICH cases from the same region in 1988. Initial computed tomography images of the head were reviewed, and ICH volumes were calculated using consistent methodology. Results: From 2008 through 2012, we identified 1117 cases of ICH. The median volume of ICH was 14.0 mL and was lower in black (11.6) than in white (15.5) patients. Median volumes of lobar and deep ICH were 28.8 mL and 9.8 mL, respectively. Median ICH volume changed significantly from 1988 to 2008–2012, with age-and-race-adjusted volume decreasing from 18.3 mL to 13.76 mL (p = 0.025). Conclusions: Median volume of ICH was 13.76 mL, and this should be considered in clinical trial design. Median ICH volume has apparently decreased from 1988 to 2008–2012.